Asia stocks rebound as oil retreats, Trump says Iran war could end soon
Asia stocks rebound as oil retreats, Trump says Iran war could end soon
Source link
Similar Posts
Thou Shalt Not Tariff – Fat Tail Daily
“I don’t give a s**t what you call it.” –Vice President JD Vance, after learning that killing civilians was murder Poor Donald. There are two major parts to his program: tariffs and deportations. Both are in trouble with the law. The New York Post: Federal judge blocks Trump from swiftly deporting illegal immigrants CBS News:…
On Holding names co-founders as CEOs
On Holding names co-founders as CEOs Source link
Software and data refresher after many years absence
1. I’ve never used metastock so I can’t answer this. But I’m inclined to say yes. 2. Typical choices are Amibroker, or something called RealTest. I am a big fan of RealTest. Good community, and though there is a learning curve it isn’t too bad. You can also use yahoo as your data source very…
Ambuja Cements shares rise marginally after Q2 PAT surges 268% YoY, brokerages hike target price. Should you buy?
Shares of Ambuja Cements rose 1% to hit an intraday high of Rs 588.55 on the BSE on Tuesday after the Adani Group-owned cement major posted a stellar 268% year-on-year (YoY) jump in its consolidated net profit to Rs 1,766 crore for the July-September quarter (Q2 FY26), compared to Rs 479 crore in the year-ago…
How this rare disease biotech is reshaping the future and why investors are paying close attention 💡
Zevra Therapeutics has recently made a series of notable announcements that have captured the attention of investors, analysts, and those following developments in the rare disease pharmaceuticals sector. As it undertakes strategic organizational shifts, reports strong financial metrics, and earns supportive analyst forecasts, the company appears committed to building a robust pipeline of treatments for…
Ozempic Boom: Hims & Eli Lilly Lead Healthcare Bets
Most investors have noticed that most stocks in the healthcare sector have declined to levels not seen in a while, making this an area of interest for those looking into the next potential upswing in their portfolios. However, for those who are okay with individual stock picking and taking on a bit more risk, there…
